Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Envoy Medical, Inc. Director's Dealing 2024

Jun 17, 2024

34992_dirs_2024-06-17_153f35f6-2df8-4444-a15e-9a84ef4be31e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Envoy Medical, Inc. (COCH)
CIK: 0001840877
Period of Report: 2024-06-07

Reporting Person: Crowe Michael Curtis (Director)